CompanyDeals

Ji Xing Pharmaceuticals and TSH Biopharm Announce Collaboration for Dry Eye Treatment in Taiwan

CompanyDrug

Hrain Biotechnology’s Anti-CD70 T Cell Therapy HR010 Gets Tacit Approval for Renal Cancer Trial

CompanyDrug

Huadong Medicine’s Elahere Receives Approval for FRα Positive Cancer Treatment in China

CompanyDeals

WuXi Biologics Proposes Spin-Off and Listing of WuXi XDC on Hong Kong Stock Exchange

CompanyDrug

Jiangxi Jemincare Group Launches Omalizumab Biosimilar CMAB007 in China for Asthma and Dermatology

CompanyDeals

Zhejiang Doer Biologics Partners with BioNTech for Global Development of Innovative Biological Drugs

CompanyDrug

C4 Therapeutics’ CFT8919 Earns FDA Approval for Clinical Trials Targeting EGFR L858R Mutations

Policy / Regulatory

NHSA’s 2022 Report: BMI Fund Income Rises 7.6%, Outgoing Expenditure Increases 2.3%

CompanyDrug

Zai Lab’s Vyvgart Receives NMPA Review for Subcutaneous Injection Form in gMG Treatment

CompanyMedical Device

Sino Medical Sciences Receives Approval for Next-Generation Drug-Eluting Stent in Indonesia

Policy / Regulatory

Shanghai’s SMPA Initiates Volume-Based Procurement for National VBP Drugs in Alliance Region

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for HRS-9815 Radiodiagnostic Drug Clinical Study